Oxford BioDynamics Plc
OBD.L · LSE
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | £1,095 | £636 | £510 | £154 |
| % Growth | 72.2% | 24.7% | 231.2% | – |
| Cost of Goods Sold | £7,244 | £347 | £244 | £38 |
| Gross Profit | -£6,149 | £289 | £266 | £116 |
| % Margin | -561.6% | 45.4% | 52.2% | 75.3% |
| R&D Expenses | £615 | £809 | £758 | £526 |
| G&A Expenses | £0 | £4,479 | £3,411 | £2,452 |
| SG&A Expenses | £3,899 | £4,479 | £3,411 | £2,452 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £7,895 | £6,265 | £5,739 |
| Operating Expenses | £4,514 | £13,183 | £10,434 | £8,717 |
| Operating Income | -£10,663 | -£12,894 | -£11,026 | -£8,601 |
| % Margin | -973.8% | -2,027.4% | -2,162% | -5,585.1% |
| Other Income/Exp. Net | -£759 | £938 | -£416 | £1,034 |
| Pre-Tax Income | -£11,422 | -£11,956 | -£11,411 | -£7,567 |
| Tax Expense | -£269 | -£389 | -£585 | -£857 |
| Net Income | -£11,153 | -£11,567 | -£10,826 | -£6,710 |
| % Margin | -1,018.5% | -1,818.7% | -2,122.7% | -4,357.1% |
| EPS | -0.008 | -0.045 | -0.073 | -0.067 |
| % Growth | 82.3% | 38.4% | -9.1% | – |
| EPS Diluted | -0.008 | -0.045 | -0.073 | -0.067 |
| Weighted Avg Shares Out | 1,387,075 | 255,729 | 147,482 | 99,702 |
| Weighted Avg Shares Out Dil | 1,387,075 | 255,729 | 147,482 | 99,702 |
| Supplemental Information | – | – | – | – |
| Interest Income | £63 | £112 | £72 | £11 |
| Interest Expense | £422 | £225 | £213 | £195 |
| Depreciation & Amortization | £1,199 | £1,466 | £1,357 | £1,213 |
| EBITDA | -£9,801 | -£10,265 | -£9,841 | -£6,159 |
| % Margin | -895.1% | -1,614% | -1,929.6% | -3,999.4% |